HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon, Inc. (NYSE: ACL) announced today that its affiliate Alcon Laboratories, Inc. has signed a five year contract with LCA-Vision, Inc. (NASDAQ: LCAV). Under the contract, LCA will place ALLEGRETTO WAVE® Eye-Q 400Hz excimer lasers in all of the company’s 75 LasikPlus® vision surgery centers by the end of the third quarter of 2009. The contract comes as part of a decision by LCA to standardize its laser surgery technology on two laser platforms based on the results of a clinical study.
